Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)
Background The efficacy and safety of rivaroxaban have been demonstrated in phase 3 trials of patients with venous thromboembolism (VTE; pulmonary embolism [PE] and deep vein thrombosis [DVT]). Data regarding rivaroxaban treatment of VTE in routine Japanese clinical practice remain limited....
Enregistré dans:
Auteurs principaux: | Ikuo Fukuda, Atsushi Hirayama, Kazuo Kawasugi, Takao Kobayashi, Hideaki Maeda, Mashio Nakamura, Norifumi Nakanishi, Norikazu Yamada, Tsubasa Tajima, Sanghun Iwashiro, Yutaka Okayama, Toshiyuki Sunaya, Kazufumi Hirano, Takanori Hayasaki |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Georg Thieme Verlag KG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/313ff2ce01f142e49eb686e8b2f02342 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Rivaroxaban triggered multifocal intratumoral hemorrhage of the cabozantinib-treated diffuse brain metastases: A case report and review of literature
par: Chen Luyue, et autres
Publié: (2021) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
par: Victoria Speed, et autres
Publié: (2021) -
Mean platelet volume as a prognostic factor for venous thromboembolic disease
par: Díaz,Juan Manuel, et autres
Publié: (2019) -
Frecuencia de tromboembolismo venoso en pacientes hospitalizados con cáncer. Factores de riesgo y eficacia de la tromboprofilaxis farmacológica
par: Conte L,Guillermo, et autres
Publié: (2008) -
Profilaxis de enfermedad tromboembólica en pacientes hospitalizados con patología médica, estrechando la brecha entre las guías y la práctica clínica
par: Aizman,Andrés, et autres
Publié: (2011)